Clinical Trial Update: Comparison of AVD + Low-Dose Nivolumab vs. PET-Adapted BEACOPP-like in Advanced cHL [Phase 2]

View source ↗

Summary

An ongoing Phase 2 trial comparing AVD with low-dose nivolumab versus PET-adapted BEACOPP-like therapy in advanced classical Hodgkin lymphoma; recruitment is on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Adriamycin (doxorubicin)
• Dacarbazine (dacarbazine)
• OPDIVO (nivolumab)
• Vinblastine (vinblastine)

Snippet

Sponsor: St. Petersburg State Pavlov Medical University | Conditions: Hodgkin Lymphoma | Phase 2 | Status: RECRUITING